High-Affinity Fully Functional Soluble Single-Domain Human CD4, Antibodies, and Related Fusion Proteins
European Patent
21185510.1
Filed on 2021-07-14
21185510.1
Filed on 2021-07-14
IMMUNORESPONSIVE CELLS EXPRESSING DOMINANT NEGATIVE FAS AND USES THEREOF
European Patent
19865927.8
Filed on 2019-09-30
19865927.8
Filed on 2019-09-30
MYC G-QUADRUPLEX STABILIZING SMALL MOLECULES AND THEIR USE
US Application 17/306,756
Filed on 2021-05-03
Filed on 2021-05-03
SIZE-DEPENDENT BRAIN AND LYMPHATIC DISTRIBUTION OF MACROMOLECULAR DRUG DELIVERY PLATFORM
Patent Cooperation Treaty
PCT/US2021/036548
Filed on 2021-06-09
PCT/US2021/036548
Filed on 2021-06-09
TP5, A PEPTIDE INHIBITOR OF ABERRANT AND HYPERACTIVE CDK5/P25 AS TREATMENT FOR CANCER
US Application 17/294,011
Filed on 2021-05-14
Filed on 2021-05-14
TP5, A PEPTIDE INHIBITOR OF ABERRANT AND HYPERACTIVE CDK5/P25 AS TREATMENT FOR CANCER
European Patent
19817052.4
Filed on 2021-06-10
19817052.4
Filed on 2021-06-10
TP5, A PEPTIDE INHIBITOR OF ABERRANT AND HYPERACTIVE CDK5/P25 AS TREATMENT FOR CANCER
Canada
3119736
Filed on 2021-05-12
3119736
Filed on 2021-05-12
IMMUNORESPONSIVE CELLS EXPRESSING DOMINANT NEGATIVE FAS AND USES THEREOF
US Application 17/214,436
Filed on 2021-03-26
Filed on 2021-03-26
IMMUNORESPONSIVE CELLS EXPRESSING DOMINANT NEGATIVE FAS AND USES THEREOF
Japan
2021-517344
Filed on 2019-09-30
2021-517344
Filed on 2019-09-30